Premium Nahrungsergänzungsmittel | artgerecht

DGCR8 – Function, Genetics and Clinical Significance

DGCR8 is a key RNA-binding protein essential for microRNA biogenesis, located on chromosome 22q11.2 and linked to DiGeorge syndrome and various cancers.

Regular tips about health Regular tips about health

Things worth knowing about "DGCR8"

DGCR8 is a key RNA-binding protein essential for microRNA biogenesis, located on chromosome 22q11.2 and linked to DiGeorge syndrome and various cancers.

What is DGCR8?

DGCR8 (DiGeorge Critical Region 8) is a highly conserved, nuclear RNA-binding protein that plays an essential role in the biogenesis of microRNAs (miRNAs). Its encoding gene is located on chromosome 22q11.2 – a genomic region that is typically deleted in patients with DiGeorge syndrome (also known as 22q11.2 deletion syndrome). Together with the ribonuclease III enzyme Drosha, DGCR8 forms the Microprocessor complex, which is responsible for the first critical processing step of primary miRNA precursors (pri-miRNAs).

Biological Function and Mechanism of Action

MicroRNAs are short, non-coding RNA molecules that regulate gene expression at the post-transcriptional level. Their biogenesis involves several key steps:

Transcription: In the cell nucleus, RNA polymerase II transcribes long primary miRNA transcripts (pri-miRNAs) from genomic DNA.
Primary processing by the Microprocessor complex: DGCR8 recognizes and binds the characteristic hairpin structure of pri-miRNAs. It precisely positions Drosha to cleave the pri-miRNA into an approximately 60–70 nucleotide hairpin precursor (pre-miRNA).
Nuclear export: The pre-miRNA is exported from the nucleus to the cytoplasm via the Exportin-5/Ran-GTP system.
Secondary processing: In the cytoplasm, the enzyme Dicer cleaves the pre-miRNA into a mature miRNA duplex.
RISC loading: The mature miRNA strand is incorporated into the RNA-induced silencing complex (RISC), where it guides sequence-specific silencing of target messenger RNAs (mRNAs).

DGCR8 acts as a molecular anchor that determines the substrate specificity of the Microprocessor complex. Without functional DGCR8, miRNA biogenesis is severely impaired, with widespread consequences for gene regulation throughout the body.

Clinical Relevance

DiGeorge Syndrome and 22q11.2 Deletion Syndrome

22q11.2 deletion syndrome (also called DiGeorge syndrome or velocardiofacial syndrome) is caused by a microdeletion on chromosome 22q11.2. Because the DGCR8 gene resides within this region, affected individuals carry only one functional copy of the gene (haploinsufficiency). This reduces the overall miRNA processing capacity of cells and contributes to the diverse clinical features of the syndrome, including:

Congenital heart defects
Cleft palate
Immune deficiencies due to thymic dysplasia
Developmental delays and intellectual disability
Increased risk of psychiatric disorders, particularly schizophrenia

DGCR8 and Cancer

Mutations and altered expression levels of DGCR8 have been reported in several malignancies. Because DGCR8 controls global miRNA biogenesis, its loss can impair the expression of numerous tumor-suppressive miRNAs. Key associations include:

Thyroid tumors (including follicular thyroid carcinoma): Specific somatic mutations in DGCR8 have been identified in certain thyroid neoplasms.
Wilms tumor (nephroblastoma): Alterations in the miRNA processing pathway, including DGCR8 mutations, are implicated in this pediatric kidney tumor.
Other carcinomas: Dysregulated DGCR8 expression has been observed in breast, lung, and colorectal cancers.

DGCR8 as a Research Target

Given its central role in miRNA biogenesis, DGCR8 is an active target of research in oncology and neurobiology. Pharmacological modulation of the Microprocessor complex is being explored as a potential therapeutic strategy, for example to restore miRNA-mediated tumor suppression in cancer cells.

Diagnostics

Detection of DGCR8 deletions or mutations is achieved through several molecular genetic methods:

Array-CGH (Comparative Genomic Hybridization): For detection of the 22q11.2 deletion in DiGeorge syndrome.
FISH (Fluorescence In Situ Hybridization): For visualization of the specific chromosomal region.
Next-Generation Sequencing (NGS): For identification of somatic point mutations in tumor tissue.
RT-PCR and Western Blot: For quantification of DGCR8 expression and protein levels in research settings.

References

Shiohama A. et al. - Molecular cloning and expression analysis of a gene expressed from the DiGeorge chromosomal region. Biochemical and Biophysical Research Communications, 2003.
Han J. et al. - The Drosha-DGCR8 complex in primary microRNA processing. Genes & Development, 2004; 18(24):3016–3027.
Brosens L.A. et al. - DICER1 and DGCR8 mutations in tumors: clinical and molecular implications. Endocrine-Related Cancer, 2020.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category

Pionier in Lactoferrin & naturbasierten Nutraceuticals seit 2016

130k Empfänger: Werde Teil der Community!

Wissenschaftliche Beiträge, Ernährungs- & Gesundheitstipps, sowie Zugang zu exklusiven Angeboten. Melde Dich an & sichere Dir 10% Nachlass auf Deinen nächsten Einkauf.